Bristol Myers Squibb will present at the 46th Annual TD Cowen Health Care Conference on March 4, 2025, the company announced February 26, 2025. The presentation, a fireside chat, will start at 2:30 p.m. Eastern Time. The company also plans to participate in the Leerink Partners 2025 Global Healthcare Conference on March 12, 2025, at 11:20 a.m. ET, also in a fireside chat format. Investors and members of the public can access both presentations via the Bristol Myers Squibb investor relations website. Archived recordings will be made available following each session. Adam Lenkowsky, Executive Vice President and Chief Commercial Officer, is listed as a company participant in the TD Cowen conference, according to available information. Bristol Myers Squibb described itself as a global biopharmaceutical company focused on the discovery, development, and delivery of innovative medicines for serious diseases. The company’s announcement did not detail the specific topics to be addressed at either conference. As of February 26, 2025, Bristol Myers Squibb’s stock was trading on the Latest York Stock Exchange under the ticker symbol BMY. The company’s media and investor relations contacts were listed as [email protected] and [email protected], respectively.
Bristol Myers Squibb at TD Cowen Health Care Conference 2024
